Articles

Find an Article

Filter articles

Applied Filters

Showing 41 to 50 of 273 results

LSIPR 50 2018: Martyn Andrews

UK21-08-2018

Martyn Andrews was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

Event preview: BioPharm America 2018

US06-08-2018Kari Luu

BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports.

LSIPR 50 2018: Manuel Salmeron-Sanchez and Matthew Dalby

UK01-08-2018

Manuel Salmeron-Sanchez and Matthew Dalby were selected in the LSIPR 50 2018 publication for​ ​their influence on the life sciences industry. They featured in the business and innovation section, as LSIPR reports.

LSIPR 50 2018: Naoko Munakata

Japan30-07-2018

Naoko Munakata was selected in the LSIPR 50 2018 publication for​ ​her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Raymond Chen and Kathleen O’Malley

US20-07-2018

Raymond Chen and Kathleen O’Malley were selected in the LSIPR 50 2018 publication for​ ​their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Backing the innovators

US17-07-2018

Josh Makower, partner at venture capital investor New Enterprise Associates, explains to LSIPR the firm’s role in supporting medtech innovation, his sweet spot when it comes to projects, and how to balance what is medically relevant with commercial viability.

The future of precision medicine part 2: data is king

International, UK17-07-2018Daniel Lim

In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports.

Will the EPO’s Enlarged Board hear the Broad’s CRISPR case?

EPO13-07-2018Jakob Wested, Timo Minssen, Esther van Zimmeren

As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.

LSIPR 50 2018: Leading the transformation change

US12-07-2018

Scott Alban of AstraZeneca outlines the company’s recent transformation aimed at breaking down barriers and the uncharted territories that it is eager to explore.

LSIPR 50 2018: Helping to shape the healthcare landscape

Nigeria10-07-2018

A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank.

Showing 41 to 50 of 273 results

LSIPR